These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9867302)

  • 1. Prevention of venous thrombosis after elective hip surgery.
    Turpie AG; Kher A
    Orthopedics; 1998 Dec; 21(12):1275-81. PubMed ID: 9867302
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of clinical trials of low molecular weight heparins.
    Bergqvist D
    Eur J Surg; 1992 Feb; 158(2):67-78. PubMed ID: 1350218
    [No Abstract]   [Full Text] [Related]  

  • 3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and therapy of postoperative thrombosis and embolism.
    Röggla M; Wagner A; Malzer R; Gamper G; Janata K; Röggla G
    Acta Anaesthesiol Scand Suppl; 1997; 111():217-9. PubMed ID: 9421020
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.
    Lancet; 2000 Apr; 355(9212):1295-302. PubMed ID: 10776741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended thromboprophylaxis following lower limb arthroplasty: what do the clinical trials mean?
    Cohen AT; Khushal A
    Haemostasis; 2000; 30 Suppl 2():88-94; discussion 82-3. PubMed ID: 11251349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture.
    Monreal M; Lafoz E; Navarro A; Granero X; Caja V; Caceres E; Salvador R; Ruiz J
    J Trauma; 1989 Jun; 29(6):873-5. PubMed ID: 2544742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.
    Collins R; Scrimgeour A; Yusuf S; Peto R
    N Engl J Med; 1988 May; 318(18):1162-73. PubMed ID: 3283548
    [No Abstract]   [Full Text] [Related]  

  • 9. Venous thromboembolism prophylaxis after total hip or knee arthroplasty: a survey of Canadian orthopedic surgeons.
    Gross M; Anderson DR; Nagpal S; O'Brien B
    Can J Surg; 1999 Dec; 42(6):457-61. PubMed ID: 10593248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A short course of low-molecular-weight heparin to prevent deep venous thrombosis after elective total hip replacement.
    Gallay S; Waddell JP; Cardella P; Morton J
    Can J Surg; 1997 Apr; 40(2):119-23. PubMed ID: 9126125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic data related to venous thromboembolism.
    Clagett GP
    Ann Vasc Surg; 1988 Oct; 2(4):402-5. PubMed ID: 3066391
    [No Abstract]   [Full Text] [Related]  

  • 12. Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.
    Hull RD; Pineo GF; Stein PD; Mah AF; MacIsaac SM; Dahl OE; Ghali WA; Butcher MS; Brant RF; Bergqvist D; Hamulyák K; Francis CW; Marder VJ; Raskob GE
    Arch Intern Med; 2001 Sep; 161(16):1952-60. PubMed ID: 11525697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of postoperative deep vein thrombosis of the lower limbs].
    Baeshko AA; Sysov AV; Rolevich AI
    Klin Khir; 1998; (2):38-41. PubMed ID: 9615084
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with ximelagatran in orthopaedic surgery.
    Eriksson B
    Drugs; 2004; 64 Suppl 1():27-35. PubMed ID: 15586625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and tolerance of the low molecular weight heparin fraction CY 216 in preventing postoperative venous thromboembolism].
    Kakkar VV
    Med Klin Suppl; 1986 Oct; 3():13-6. PubMed ID: 3550366
    [No Abstract]   [Full Text] [Related]  

  • 16. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthopaedic surgery as a model for drug development in thrombosis.
    Dahl OE
    Drugs; 2004; 64 Suppl 1():17-25. PubMed ID: 15586624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose subcutaneous heparin versus oral anticoagulants in the prevention of postoperative deep-venous thrombosis. A controlled clinical trial.
    van Vroonhoven TJ; van Zijl J; Muller H
    Lancet; 1974 Mar; 1(7854):375-8. PubMed ID: 4131031
    [No Abstract]   [Full Text] [Related]  

  • 20. [What is assured in drug prevention of thrombosis with special reference to low molecular weight heparin?].
    Daiss W; Dölle W
    Internist (Berl); 1989 Dec; 30(12):784-9. PubMed ID: 2559898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.